Webinaire

2022-06-23 AMR: Les vaccins comme outils de prévention de la RAM - VIDEO

Webinar recording

Langues

  • Français

Année de publication

2022

Type

Webinaire

Catégories

  • Initiatives mondiales

Références sur le sujet

GVIRF-webinar

TitreAuteurAnnéeTypeLangue
2021-10-14 mRNA Vaccine Technologies for Global Health - AGENDAGVIRF Secretariat2021PresentationAnglais
2021-10-14 mRNA Vaccine Technologies for Global Health - PRESENTATIONSGVIRF Secretariat2021PresentationAnglais
2021-10-14 mRNA Vaccine Technologies for Global Health - VIDEOGVIRF Secretariat2022WebinarAnglais
2022-03-03 Malaria Vaccine R&D and Immunization Lessons Learned and Considerations for Global Health Impact - VIDEOGVIRF Secretariat2022WebinarAnglais
2022-03-03 Malaria Vaccine R&D and Immunization: Lessons Learned and Considerations for Global Health Impact - AGENDAGVIRF Secretariat2022PresentationAnglais
2022-06-23 AMR: Las vacunas como herramientas para prevenir la RAM - VIDEOGVIRF Secretariat2022WebinarEspagnol
2022-06-23 AMR: Les vaccins comme outils de prévention de la RAM - VIDEOGVIRF Secretariat2022WebinarFrançais
2022-06-23 AMR: Vaccines as Tools to Prevent Antimicrobial Resistance - VIDEOGVIRF Secretariat2022WebinarAnglais
2022-06-23 AMR: Vaccines as Tools to Prevent Antimicrobial Resistance: Advances, challenges, and future development - AGENDAGVIRF Secretariat2022PresentationAnglais
2022-06-23 Vaccines as Tools to Prevent Antimicrobial Resistance: Advances, challenges, and future development - WEBINAR ANNOUNCEMENTGVIRF Secretariat2022PresentationAnglais
2022-10-12 Correlates of Protection - VIDEOGVIRF Secretariat2022WebinarAnglais
2023-09-13 Webinar: Vaccine Adjuvants for Global Health - Final AGENDAGVIRF Secretariat2023WebinarAnglais
2023-09-13 Webinar: Vaccine Adjuvants for Global Health - Session I Global Demand for Vaccine AdjuvantsGVIRF Secretariat2023PresentationAnglais
2023-09-13 Webinar: Vaccine Adjuvants for Global Health - Session II Selection of Adjuvant and Formulation for Vaccine R&D: rational or empirical?GVIRF Secretariat2023PresentationAnglais
2023-09-13 Webinar: Vaccine Adjuvants for Global Health - Session III Access to AdjuvantsGVIRF Secretariat2023PresentationAnglais
2023-09-13 Webinar: Vaccine Adjuvants for Global Health - VIDEOGVIRF Secretariat2023WebinarAnglais
2024-0222 GVIRF Webinar: New TB Vaccines for Adults & Adolescents: Progress, Prospects and Perspectives; February 22, 2024 - FINAL AGENDAGVIRF Secretariat2024WebinarAnglais
2024-0222 GVIRF Webinar: New TB Vaccines for Adults and Adolescents - VIDEOGVIRF Secretariat2024WebinarAnglais
2024-0222 GVIRF Webinar: New TB Vaccines for Adults and Adolescents, Progress, Prospects, and Perspectives, February 22, 2024 - ANNOUNCEMENTGVIRF Secretariat2024WebinarAnglais
2024-0222 GVIRF Webinar: New Tuberculosis Vaccines for Adults and Adolescents: Progress, Prospects, and Perspectives - PRESENTATIONSGVIRF Secretariat, Richard White, Nebiat Gebreselassie, Mark Hatherill, Ann Ginsberg, Nicole Frahm, Munyaradzi Musvosvi, David Lewinsohn, Shelly Malhotra, Rupali Limaye, Birgitte Giersing2024PresentationAnglais
2024-0222 GVIRF Webinar: Nouveaux vaccins antituberculeux pour adultes et adolescents - VIDEOGVIRF Secretariat2024WebinarFrançais
2024-0222 GVIRF Webinar: Nuevas vacunas contra la tuberculosis para adultos y adolescentes - VIDEOGVIRF Secretariat2024WebinarEspagnol
2024-0730 GVIRF Webinar: New Combination Vaccines - PRESENTATIONSGVIRF Secretariat2024PresentationAnglais
2024-0730 GVIRF Webinar: New Combination Vaccines - Questions and AnswersGVIRF Secretariat2024WebinarAnglais
2024-0730 GVIRF Webinar: New Combination Vaccines - VIDEOGVIRF Secretariat2024WebinarChinois, Anglais, Français, Portuguais, Espagnol
2024-0730 GVIRF Webinar: New Combination Vaccines; July 30, 2024 - AGENDA and REGISTRATION LINKGVIRF Secretariat2024WebinarChinois, Anglais, Français, Portuguais, Espagnol
2024-1121 GVIRF Webinar: Artificial Intelligence (AI) in Vaccine Research & Development - ANNOUNCEMENT AND REGISTRATION LINKGVIRF Secretariat2024WebinarAnglais

Ajouté par: Angela Hwang

Ajouté le: 2022-12-07 06:20:00

Consultations: 1467